In patients with severe, uncontrolled chronic rhinosinusitis with nasal polyps, dupilumab showed sustained efficacy, enabling a substantial proportion to extend the dosing interval.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/dupilumab-shows-sustained-benefits-chronic-rhinosinusitis-2025a1000o3r?src=rss
Author :
Publish date : 2025-09-11 13:10:00
Copyright for syndicated content belongs to the linked Source.